title: Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derived PCV2 vaccine-induced immunity on vaccination.
abstract: The objectives of this study were (1) to compare the efficacy of two different PCV2 vaccination protocols (colostrum-derived immunity versus piglet vaccination) in a conventional PCV2 growing pig challenge model and (2) to evaluate the efficacy of vaccinating piglets with the same vaccine used in the dams. Two different commercially available vaccines (VAC1; VAC2) were used in the same experiment. Seventy-eight piglets born to vaccinated or non-vaccinated sows were divided into 8 groups. A proportion of the pigs with and a proportion of the pigs without passively acquired immunity were vaccinated at 21 days of age. All pigs except negative controls were challenged with PCV2b at 35 days post-vaccination and necropsied at 21 days post-challenge (dpc). The data indicates that both dam vaccination and piglet vaccination had similar efficacies in reducing PCV2 viral loads and antigen levels in the growing pigs. Interestingly, dam vaccination alone did result in significantly (P<0.05) lower anti-PCV2-antibodies levels at challenge in piglets from dams immunized with VAC2 compared to piglets from VAC1 immunized dams. When data obtained from the growing piglets that were vaccinated with VAC1 or VAC2 were compared, antibody levels and reduction of incidence of PCV2-antigen were not different; however, piglets vaccinated with VAC2 had reduced PCV2-DNA genomic copies in serum by 21 dpc. Vaccination of piglets with the same vaccine as was used on their dams did not appear to affect vaccine efficacy as piglets in these groups had anti-PCV2-antibody levels and PCV2 genomic copies similar to the groups where vaccine was administered to the piglets only.
authors.affiliation: Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011, USA. tanjaopr@iastate.edu
authors.forename: Tanja
authors.initials: T
authors.lastname: Opriessnig
authors.forename: Abby R
authors.initials: AR
authors.lastname: Patterson
authors.forename: Darin M
authors.initials: DM
authors.lastname: Madson
authors.forename: Narinder
authors.initials: N
authors.lastname: Pal
authors.forename: Sheela
authors.initials: S
authors.lastname: Ramamoorthy
authors.forename: Xiang-Jin
authors.initials: XJ
authors.lastname: Meng
authors.forename: Patrick G
authors.initials: PG
authors.lastname: Halbur
mesh_terms: D056704:Adaptive Immunity / Q000276:immunology*; D000818:Animals; D057134:Antibodies, Neutralizing / Q000097:blood; D000914:Antibodies, Viral / Q000097:blood; D018173:Circoviridae Infections / Q000276:immunology / Q000662:veterinary*; D017925:Circovirus / Q000235:genetics / Q000276:immunology; D003126:Colostrum / Q000276:immunology; D004279:DNA, Viral / Q000097:blood; D005260:Female; D007116:Immunization, Passive / Q000662:veterinary*; D011247:Pregnancy; D011897:Random Allocation; D013552:Swine; D013553:Swine Diseases / Q000276:immunology* / Q000517:prevention & control; D013997:Time Factors; D014611:Vaccination / Q000662:veterinary*; D014612:Vaccines / Q000276:immunology*
chemical_list: D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D004279:DNA, Viral; D014612:Vaccines